132 related articles for article (PubMed ID: 20029960)
1. The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.
Ren L; Li Y; Li Y; Tang R; Hu D; Sheng Z; Liu N
Cell Biochem Funct; 2010 Jan; 28(1):58-65. PubMed ID: 20029960
[TBL] [Abstract][Full Text] [Related]
2. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z
Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478
[TBL] [Abstract][Full Text] [Related]
3. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
4. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
Jing L; Li WM; Zhou LJ; Li S; Kou JJ; Song J
Alcohol Clin Exp Res; 2008 Nov; 32(11):1999-2007. PubMed ID: 18783396
[TBL] [Abstract][Full Text] [Related]
5. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
Kusunoki H; Taniyama Y; Rakugi H; Morishita R
J Am Heart Assoc; 2013 Apr; 2(2):e000103. PubMed ID: 23608606
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.
Molavi B; Chen J; Mehta JL
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H687-93. PubMed ID: 16582019
[TBL] [Abstract][Full Text] [Related]
9. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
[TBL] [Abstract][Full Text] [Related]
10. Role of the renin-angiotensin system in cardiac hypertrophy.
Yamazaki T; Komuro I; Yazaki Y
Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
[TBL] [Abstract][Full Text] [Related]
11. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Gaikwad AB; Viswanad B; Ramarao P
Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
13. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
Sakuta T; Morita Y; Satoh M; Fox DA; Kashihara N
Arthritis Rheum; 2010 May; 62(5):1319-28. PubMed ID: 20213806
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Ruzicka M; Yuan B; Harmsen E; Leenen FH
Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
[TBL] [Abstract][Full Text] [Related]
17. AT1 receptor participates in the cardiac hypertrophy induced by resistance training in rats.
Barauna VG; Magalhaes FC; Krieger JE; Oliveira EM
Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R381-7. PubMed ID: 18495827
[TBL] [Abstract][Full Text] [Related]
18. PPARγ activation improves the molecular and functional components of I(to) remodeling by angiotensin II.
Nanayakkara G; Viswaprakash N; Zhong J; Kariharan T; Quindry J; Amin R
Curr Pharm Des; 2013; 19(27):4839-47. PubMed ID: 23323617
[TBL] [Abstract][Full Text] [Related]
19. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Jones ES; Black MJ; Widdop RE
J Mol Cell Cardiol; 2004 Nov; 37(5):1023-30. PubMed ID: 15522279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
